A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients

NCT00001282 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Zidovudine (AZT) & Interleukin-2 (IL2)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)